Pharmacy Benefit Managers (PBMs)

Trump Signs $1.2T Spending Package That Funds HHS, Enacts PBM Reforms, Telehealth and Hospital-at-Home Measures

President Donald Trump on Tuesday afternoon signed a massive funding package that ends a brief government shutdown and provides full-year funding for the federal government through the end of the year. The legislation also finalizes several key healthcare extenders including provisions of the Medicare telehealth program and the Acute Hospital Care at Home waiver as

Trump Signs $1.2T Spending Package That Funds HHS, Enacts PBM Reforms, Telehealth and Hospital-at-Home Measures Read More »

MedImpact Completes Acquisition of Sav-Rx

MedImpact Healthcare Systems, Inc., the nation’s largest independent pharmacy benefit and health solutions company, announces the completion of its acquisition of Sav-Rx, a pharmacy benefit manager with more than five decades of experience serving organized labor. Sav-Rx brings a proven, high-touch approach to pharmacy benefit management and a deep understanding of labor-sponsored plans. Combined with

MedImpact Completes Acquisition of Sav-Rx Read More »

PBMs Hit by Trump Transparency Rule

Pharmacy benefit managers are facing more pressure after the Department of Labor issued new requirements for disclosing their financial dealings with drugmakers, pharmacies and others health system players. The proposed rule stems from President Trump’s executive order on lowering drug prices and comes as Congress is targeting the drug supply intermediaries with more transparency rules.

PBMs Hit by Trump Transparency Rule Read More »

Middlemen in the U.S. Healthcare System: Shaping Costs and Complexity

Healthcare middlemen aggregate purchasing power, streamline transactions and manage claims, yet their operations also affect transparency, competition and the cost of goods and services. Employers rely on middlemen to navigate health insurance benefits and claims processing, providers depend on them to manage supply chains and revenue cycles, while patients experience the downstream consequences of middlemen

Middlemen in the U.S. Healthcare System: Shaping Costs and Complexity Read More »

House Report Alleges CVS Aimed to Stifle Pharmacy Hub Competition

A new report from the House Judiciary Committee alleges that CVS Health may have violated antitrust laws by preventing independent pharmacies from tapping into alternative pharmacy-hub options. The report, released last week as major health insurance executives were questioned for hours before two House panels, is born from a committee investigation launched in September 2024

House Report Alleges CVS Aimed to Stifle Pharmacy Hub Competition Read More »

Scroll to Top